Engineering a Bifunctional Smart Nanoplatform Integrating Nanozyme Activity and Self-Assembly for Kidney Cancer Diagnosis and Classification
ACS Nano · 2024
DOI: 10.1021/acsnano.4c08085 ↗At a glance
Journal article in ACS Nano, 2024. Written by Dingyitai Liang and 6 co-authors. Institution: State Key Laboratory of Systems Medicine for Cancer, School of Biomedical Engineering and Institute of Medical Robotics, Division of Cardiology, Renj…. Major MEDLINE topics: Kidney Neoplasms, Gold, Colorimetry, Tannins. Cited 50 times so far (Crossref); 60 references. Funded by: Shanghai Jiao Tong University, National Key Research and Development Program of China, Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning.
Abstract (original language)
Accurate diagnosis and classification of kidney cancer are crucial for high-quality healthcare services. However, the current diagnostic platforms remain challenges in the rapid and accurate analysis of large-scale clinical biosamples. Herein, we fabricated a bifunctional smart nanoplatform based on tannic acid-modified gold nanoflowers (TA@AuNFs), integrating nanozyme catalysis for colorimetric sensing and self-assembled nanoarray-assisted LDI-MS analysis. The TA@AuNFs presented peroxidase (POD)- and glucose oxidase-like activity owing to the abundant galloyl residues on the surface of AuNFs. Combined with the colorimetric assay, the TA@AuNF-based sensing nanoplatform was used to directly detect glucose in serum for kidney tumor diagnosis. On the other hand, TA@AuNFs could self-assemble into closely packed and homogeneous two-dimensional (2D) nanoarrays at liquid-liquid interfaces by using Fe3+ as a mediator. The self-assembled TA@AuNFs (SA-TA@AuNFs) arrays were applied to assist the LDI-MS analysis of metabolites, exhibiting high ionization efficiency and excellent MS signal reproducibility. Based on the SA-TA@AuNF array-assisted LDI-MS platform, we successfully extracted metabolic fingerprints from urine samples, achieving early-stage diagnosis of kidney tumor, subtype classification, and discrimination of benign from malignant tumors. Taken together, our developed TA@AuNF-based bifunctional smart nanoplatform showed distinguished potential in clinical disease diagnosis, point-of-care testing, and biomarker discovery.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- State Key Laboratory of Systems Medicine for Cancer, School of Biomedical Engineering and Institute of Medical Robotics, Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shangha…
- Shanghai Jiao Tong University Sichuan Research Institute, Chengdu 610213, P. R. China.
ORCID profiles: Kun Qian
Funding
- Shanghai Jiao Tong University
- National Key Research and Development Program of China
- Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
- Innovative Research Team of High-level Local University in Shanghai
- Science and Technology Commission of Shanghai Municipality
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- Shanghai Jiao Tong University Inner Mongolia Research Institute
Cite
APA
Liang, D., Yang, S., Ding, Z., Xu, X., Tang, W., Wang, Y., & Qian, K. (2024). Engineering a Bifunctional Smart Nanoplatform Integrating Nanozyme Activity and Self-Assembly for Kidney Cancer Diagnosis and Classification. ACS Nano. https://doi.org/10.1021/acsnano.4c08085
Vancouver
Liang D, Yang S, Ding Z, Xu X, Tang W, Wang Y, et al. Engineering a Bifunctional Smart Nanoplatform Integrating Nanozyme Activity and Self-Assembly for Kidney Cancer Diagnosis and Classification. ACS Nano. 2024. doi:10.1021/acsnano.4c08085
BibTeX
@article{Liang2024,
author = {Liang, Dingyitai and Yang, Shouzhi and Ding, Ziqi and Xu, Xiaoyu and Tang, Wenxuan and Wang, Yuning and Qian, Kun},
title = {Engineering a Bifunctional Smart Nanoplatform Integrating Nanozyme Activity and Self-Assembly for Kidney Cancer Diagnosis and Classification},
journal = {ACS Nano},
year = {2024},
doi = {10.1021/acsnano.4c08085}
}
EUVIMED